Company Filing History:
3 out of 16 
2 out of 230 
Years Active: 2017-2025
Title: Lynne Hampson: Innovator in Pharmaceutical Compositions
Introduction
Lynne Hampson is a notable inventor based in Manchester, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating conditions associated with Herpes Simplex Virus (HSV) infection. With a total of five patents to her name, Hampson's work has the potential to impact the treatment of various skin conditions.
Latest Patents
Hampson's latest patents include innovative methods and compositions for treating and inhibiting the development of conditions caused by HSV infection. One of her key inventions involves compositions comprising lopinavir, either alone or in combination with ritonavir. These pharmaceutical compositions are designed for use as medicaments, specifically targeting the treatment and prevention of HSV-related conditions. Additionally, she has developed formulations for dermal application that contain a therapeutically effective amount of lopinavir and ritonavir, which are useful in treating skin cancers and premalignant dermal conditions.
Career Highlights
Throughout her career, Lynne Hampson has worked with reputable organizations, including Douglas Pharmaceuticals Limited and The University of Manchester. Her experience in these institutions has allowed her to advance her research and contribute to the development of effective pharmaceutical solutions.
Collaborations
Hampson has collaborated with notable individuals in her field, including Ian Hampson and Fergus Cameron Binnie. These partnerships have likely enhanced her research and innovation efforts.
Conclusion
Lynne Hampson is a distinguished inventor whose work in pharmaceutical compositions has the potential to revolutionize the treatment of HSV-related conditions and skin cancers. Her contributions to the field are invaluable and demonstrate her commitment to advancing medical science.